Shelf-life 24 months at 5-37 °C • Portable and compact • Blood grouping on location • Result after just 2 minutes • Easy to learn, easy to use • No need for refrigeration and daily controls • Whole blood can be used down to 5 μl • No need for separation of red cells and blood plasma

New Cooperation with UNICEF will help mothers and children across the world


Eldon Biologicals is happy to announce that we have engaged in a new partnership with UNICEF. UNICEF works in over 190 countries and territories to save children’s lives, to defend their rights, and to help them fulfil their potential, from early childhood through adolescence. The EldonCard will provide UNICEF with a new tool strengthening its response to emergencies and other humanitarian situations, and it will support efforts to protects women’s health when they give birth, e.g. improve the efforts to address post-partum hemorrhage (PPH).

Through the new agreement between UNICEF and Eldon Biologicals, the EldonCard will be available in all UNICEF programme countries, and it can be procured by UNICEF country offices through the UNICEF Supply Division in Copenhagen.

Eldon Biologicals sincerely hope that this new agreement will facilitate global emergency responses and preparedness; and support the strengthening of health systems across UNICEF programme countries. The comparative advantages of the EldonCard include: The EldonCard has a shelf-life of 24 months at 5-37 °C; it is portable and compact; it provides blood grouping on location; results are ready after just 2 minutes; it is easy to learn and easy to use; and there is no need for refrigeration, daily controls, or electricity.

We also hope this will be the first step for UNICEF to facilitate blood type testing of pregnant women and ideally adding the prevention of Rhesus disease to its country programmes. For more information about Rhesus disease please see https://wirhe.org/rh-disease/. For more information about the AFRICARhE programme, which aims to roll-out Rhesus disease prevention in Ethiopia, Malawi and Tanzania, see https://www.foetaletherapie.nl/rh-global.

Eldon Biologicals has also been happy to learn that UNICEF has engaged with the “End Post-Partum Hemorrhage” initiative in Kenya. We are a proud supporter of this initiative and welcome all parties to join hands in this important endeavor. For more information about the End PPH initiative, see https://endpph.com/.

Sidebar